Titre : Phénylurées

Phénylurées : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reproducibility of Results
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Phénylurées : Questions médicales les plus fréquentes", "headline": "Phénylurées : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Phénylurées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-12", "dateModified": "2025-03-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Phénylurées" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dérivés du benzène", "url": "https://questionsmedicales.fr/mesh/D001555", "about": { "@type": "MedicalCondition", "name": "Dérivés du benzène", "code": { "@type": "MedicalCode", "code": "D001555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dérivés de la diphényl-urée", "alternateName": "Carbanilides", "url": "https://questionsmedicales.fr/mesh/D002224", "about": { "@type": "MedicalCondition", "name": "Dérivés de la diphényl-urée", "code": { "@type": "MedicalCode", "code": "D002224", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.202" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Imidocarbe", "alternateName": "Imidocarb", "url": "https://questionsmedicales.fr/mesh/D007095", "about": { "@type": "MedicalCondition", "name": "Imidocarbe", "code": { "@type": "MedicalCode", "code": "D007095", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.202.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Céliprolol", "alternateName": "Celiprolol", "url": "https://questionsmedicales.fr/mesh/D017272", "about": { "@type": "MedicalCondition", "name": "Céliprolol", "code": { "@type": "MedicalCode", "code": "D017272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.241" } } }, { "@type": "MedicalWebPage", "name": "Diuron", "alternateName": "Diuron", "url": "https://questionsmedicales.fr/mesh/D004237", "about": { "@type": "MedicalCondition", "name": "Diuron", "code": { "@type": "MedicalCode", "code": "D004237", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.397" } } }, { "@type": "MedicalWebPage", "name": "Linuron", "alternateName": "Linuron", "url": "https://questionsmedicales.fr/mesh/D008044", "about": { "@type": "MedicalCondition", "name": "Linuron", "code": { "@type": "MedicalCode", "code": "D008044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.515" } } } ], "about": { "@type": "MedicalCondition", "name": "Phénylurées", "alternateName": "Phenylurea Compounds", "code": { "@type": "MedicalCode", "code": "D010671", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Lin Hao", "url": "https://questionsmedicales.fr/author/Lin%20Hao", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China." } }, { "@type": "Person", "name": "Chun Wang", "url": "https://questionsmedicales.fr/author/Chun%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China. chunwang69@126.com." } }, { "@type": "Person", "name": "Qiuhua Wu", "url": "https://questionsmedicales.fr/author/Qiuhua%20Wu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China. qiuhuawu@126.com." } }, { "@type": "Person", "name": "Zhi Wang", "url": "https://questionsmedicales.fr/author/Zhi%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China." } }, { "@type": "Person", "name": "Weihua Liu", "url": "https://questionsmedicales.fr/author/Weihua%20Liu", "affiliation": { "@type": "Organization", "name": "College of Science, Hebei Agricultural University, Baoding 071001, Hebei, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "[Validation of a Dispositional Hope Scale for Chilean children and adolescents].", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/37358111", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.32641/andespediatr.v94i2.4055" } }, { "@type": "ScholarlyArticle", "name": "Machine learning classifiers predict key genomic and evolutionary traits across the kingdoms of life.", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/36747072", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-28965-7" } }, { "@type": "ScholarlyArticle", "name": "Automatic electronic reporting improved the completeness of AMI and stroke incident surveillance in Tianjin, China: a modeling study.", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/36747283", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12963-023-00300-2" } }, { "@type": "ScholarlyArticle", "name": "The usefulness of preoperative CT in colon cancer staging: impact of radiologists' experience.", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/36745207", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00261-023-03835-y" } }, { "@type": "ScholarlyArticle", "name": "[Psychometric Evaluation of a Single-Item-Screener for Sleep Disturbances].", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/36746182", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1990-0651" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Phénylurées", "item": "https://questionsmedicales.fr/mesh/D010671" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Phénylurées - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Phénylurées", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Phénylurées", "description": "Comment diagnostiquer une intoxication aux phénylurées ?\nQuels tests sont utilisés pour détecter les phénylurées ?\nQuels symptômes indiquent une exposition aux phénylurées ?\nLes phénylurées sont-elles détectables par imagerie ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Reproducibility+of+Results&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Phénylurées", "description": "Quels sont les symptômes courants des phénylurées ?\nLes phénylurées provoquent-elles des réactions allergiques ?\nPeut-on avoir des symptômes neurologiques ?\nLes symptômes varient-ils selon la dose ?\nY a-t-il des symptômes à long terme ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Reproducibility+of+Results&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Phénylurées", "description": "Comment prévenir l'exposition aux phénylurées ?\nLes travailleurs doivent-ils être formés ?\nDes contrôles réguliers sont-ils nécessaires ?\nLes enfants sont-ils plus à risque ?\nQuelles mesures de sécurité doivent être appliquées ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Reproducibility+of+Results&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Phénylurées", "description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour les phénylurées ?\nComment gérer les symptômes neurologiques ?\nLe traitement nécessite-t-il une hospitalisation ?\nY a-t-il des traitements préventifs ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Reproducibility+of+Results&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Phénylurées", "description": "Quelles complications peuvent survenir ?\nLes phénylurées peuvent-elles causer des cancers ?\nY a-t-il des effets sur la reproduction ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Reproducibility+of+Results&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Phénylurées", "description": "Quels sont les principaux facteurs de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes personnes âgées sont-elles plus à risque ?\nLes femmes enceintes doivent-elles être prudentes ?\nLes habitudes de vie influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Reproducibility+of+Results&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux phénylurées ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests sanguins et l'évaluation des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les phénylurées ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux phénylurées ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des éruptions cutanées et des nausées." } }, { "@type": "Question", "name": "Les phénylurées sont-elles détectables par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'imagerie ne détecte pas les phénylurées, des tests biochimiques sont nécessaires." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les expositions potentielles aux phénylurées." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des phénylurées ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des vertiges et des troubles digestifs." } }, { "@type": "Question", "name": "Les phénylurées provoquent-elles des réactions allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des éruptions cutanées et des démangeaisons chez certains individus." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme des convulsions ou des troubles de la coordination peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Y a-t-il des symptômes à long terme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des effets neurologiques ou rénaux peuvent persister après une exposition prolongée." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux phénylurées ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits chimiques contenant des phénylurées et portez des équipements de protection." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle." } }, { "@type": "Question", "name": "Des contrôles réguliers sont-ils nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers de l'environnement de travail peuvent réduire les risques." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets des phénylurées." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être appliquées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des gants, des masques et des lunettes de protection lors de la manipulation." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste en l'élimination de l'exposition et le soutien symptomatique." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les phénylurées ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment gérer les symptômes neurologiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anticonvulsivants peuvent être prescrits pour contrôler les convulsions." } }, { "@type": "Question", "name": "Le traitement nécessite-t-il une hospitalisation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une hospitalisation peut être nécessaire en cas de symptômes graves ou persistants." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition aux phénylurées est la meilleure prévention contre l'intoxication." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, rénales ou hépatiques peuvent se développer après exposition." } }, { "@type": "Question", "name": "Les phénylurées peuvent-elles causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien potentiel avec des cancers, mais des recherches sont nécessaires." } }, { "@type": "Question", "name": "Y a-t-il des effets sur la reproduction ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des effets néfastes sur la reproduction ont été observés dans certains modèles animaux." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens médicaux réguliers et des tests de fonction organique sont recommandés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition professionnelle, l'utilisation de produits chimiques et la génétique sont des facteurs clés." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies peuvent augmenter le risque d'effets néfastes." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus vulnérables aux effets des phénylurées." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles être prudentes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes enceintes doivent éviter l'exposition en raison des risques pour le fœtus." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie saines peuvent réduire le risque d'effets néfastes." } } ] } ] }

Sources (10000 au total)

[Validation of a Dispositional Hope Scale for Chilean children and adolescents].

According to Snyder's theory, hope is defined as a dispositional attribute consisting of two dimensions, agency and pathway thinking. This construct has been widely studied because of its association ... To assess the psychometric properties of the Dispositional Hope Scale for Chilean children and adolescents (NNA, for its acronym in Spanish).... The study was conducted on 331 NNA, aged 10 to 20 years, from different educational centers in the country. Reliability was tested with Cronbach's alpha coefficient. In addition, one-factor vs two-fac... The scale showed a Cronbach's alpha coefficient of 0.89 and an adequate fit to the two-factor model, keeping the original structure proposed by Snyder et al. It is negatively related to depressive sym... The NNA Hope Scale shows appropriate psychometric properties for its use on Chilean NNA population....

Automatic electronic reporting improved the completeness of AMI and stroke incident surveillance in Tianjin, China: a modeling study.

AMI and stroke are the leading causes of premature mortality and hospitalizations in China. Incidence data at the population level for the two diseases is limited and the reliability and completeness ... We applied the DisMod II program to model the incidence of AMI and stroke from other epidemiological indicators. Inputs include mortality rates from Tianjin's mortality surveillance system, and the po... The age and sex standardized modeled incidence per 100,000 person-year decreased (p < 0.0001) from 138 in 2007 to 119 in 2015 for AMI and increased (p < 0.0001) from 520 in 2007 to 534 in 2015 for str... Completeness of AMI and stroke incidence surveillance was low in Tianjin but has improved in recent years primarily owing to the incorporation of an automatic reporting component into the information ...

The usefulness of preoperative CT in colon cancer staging: impact of radiologists' experience.

To assess the agreement between radiologists in the detection of specific features related to T- and N-stage and evaluate accuracy in colon cancer staging.... Patients who underwent contrast-enhanced computed tomography (CECT) before surgery were enrolled and evaluated by three radiologists with different experience. Pathological data were used as the refer... Seventy five patients were evaluated. The reliability analysis was moderate to substantial for tumor location (κ = 0.853), T staging (κ = 0.531), tumor bulging (κ = 0.478), fat stranding (κ = 0.490), ... Reader's experience is one of the most important factors associated with the correct classification of colon cancer. Moreover, CECT can help depict radiological features independently associated with ...

[Psychometric Evaluation of a Single-Item-Screener for Sleep Disturbances].

Sleep disturbances are one of the most prevalent health complaints in the general population. Thus, the need for validated screening instruments and prevention measures is high. The aim of the current... Data from Saxony Longitudinal Study (SLS) is being analyzed. Based on data of 32nd wave (n=321, 172 women, 149 men, M age=48.42, SD=0.64), the G-Score Item #3 ("Have you had the following complaints i... Retestreliability for the G-Score Item #3 is 0.70 (p<0.001). Correlation with the Jenkins Sleep Scale (JSS) was r=0.79 (p<0.01). The area under the curve (AUC) is 0.92, providing evidence for a very g... This study provides evidence for the use of the G-Score Item #3 as a screening instrument for sleep disturbances by showing good psychometric properties and brevity....

Translation and cross-cultural adaptation of the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire.

There is a paucity of international data regarding self-reported lower extremity lymphedema and quality of life after surgery for gynecological cancer. Validated questionnaires are emerging, but trans... To translate and culturally adapt the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire for a Norwegian population.... Permission to use the original English versions of the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire for translation was obtained. The question... Twelve patients completed the questionnaires twice. Cronbach's alpha was 0.75 for the Gynecologic Cancer Lymphedema Questionnaire and 0.89 for the Lower Extremity Lymphedema Screening Questionnaire. T... Translation and cross-cultural adaptation of these internationally validated patient-reported outcomes questionnaires for survivors of lower extremity lymphedema in gynecological cancer was feasible. ...

Nurses' Work Methods Assessment Scale: a study of content validation.

To develop and validate the content of the Nurses' Work Methods Assessment Scale.... Methodological study conducted between January and February 2022, based on the Quality Standards for Nursing Care and Imogene King's framework. A literature review was previously undertaken to design ... The initial version consisted of 40 items organized in four work methods identified in the literature. In the first dimension, from ten items, seven were considered, and one was reformulated. Seven of... The involvement of experts has become pivotal in the development and validation of the items, providing confidence to the continuity of psychometric procedures....

Automatable end-of-life screening for older adults in the emergency department using electronic health records.

Emergency department (ED) visits are common at the end-of-life, but the identification of patients with life-limiting illness remains a key challenge in providing timely and resource-sensitive advance... This was a retrospective, observational cohort study of ED visits from adults aged ≥65 years who visited any of 9 EDs across a large regional health system between 2014 and 2019. Multivariable logisti... A total of 431,179 encounters by 123,128 adults were included in this study with a 6-month mortality rate of 12.2%. Charlson (AUROC (95% CI): 0.65 (0.64-0.69)) and Elixhauser indices (0.69 (0.68-0.70)... Prognostic models using EHR data robustly identify high mortality risk older adults in the ED for whom code status, ACP, or palliative care interventions may be of benefit. Although all tested methods...

Performance validity tests in nonlitigant patients with functional motor disorder.

Performance validity tests (PVTs) are used in neuropsychological assessments to detect patterns of performance suggesting that the broader evaluation may be an invalid reflection of an individual's ab... We enrolled 29 nonlitigant, non-compensation-seeking patients with a clinical diagnosis of FMD, 29 healthy controls, and 29 healthy simulators. Three PVTs, the Coin in the Hand Test (CIH), the Rey 15-... Functional motor disorder patients showed low rates of failure on the CIH and REY (7% and 10%, respectively) and slightly higher rates on the FTT (15%, n = 26), which implies a motor task. Their perfo... Performance validity test performance of nonlitigant, non-compensation-seeking patients with FMD ranged from 7% to 15%. Patients' performance was comparable to that of controls and significantly diffe...